Status:
COMPLETED
Placental Perfusion in the Entire Placenta and With Sonobiopsy by Ultrasound
Lead Sponsor:
Szeged University
Conditions:
Placenta Diseases
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
In this study is tested the validity of placental vascular indices obtained from placenta ultrasonographic sphere biopsy and entire placenta investigation.
Detailed Description
Although, to this date, there have been a number of human placental studies that concerned the evaluation of placental 3 dimensional power Doppler vascularization with the use of VOCAL technique, but ...
Eligibility Criteria
Inclusion
- Exclusion criteria:
- multiple pregnancy,
- abnormal (\> 3mm) nuchal translucency from 11+0 to 13+6 weeks of gestation,
- the fetal or neonatal structural or chromosomal anomaly,
- inadequate localization of the placenta (placenta praevia),
- self-reported drugs, alcohol, caffeine or nicotine abuse,
- exposed to circulatory medication (oxerutins, calcium dobesilate)
- or not signing the consent form.
- If the mother suffer from er systemic disease (e.g. diabetes, autoimmune disease, vasculitis, haemophilia, thrombophilia, HIV infection, etc)
- Inclusion clriteria:
- single pregnancy
- healthy pregnant women
- no anatomical alteration of fetus
- no genetical abnormality of fetus
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05245279
Start Date
January 1 2018
End Date
January 1 2021
Last Update
February 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitiy of Szeged
Szeged, Hungary, 6720